Skip to main contentLast updated: 21-Nov-2026
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Liver Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience
In short
The biggest changes are tests that read the tumour’s own genes, targeted tablets for some of those changes, and an immune medicine added to chemotherapy.
Surgery is still the only way to remove the cancer for good. The new medicines help when it cannot be removed or comes back.
Several ideas, such as chemotherapy before surgery and blood DNA tests, are still being tested and are not routine.
For the complete picture of this cancer, from tests to surgery and medicines, read our biliary tract cancer treatment page. This post answers one question: what is new, and what is still only a trial.
Three things: tumour gene tests, targeted tablets for some tumours, and an immune medicine given with chemotherapy. Surgery itself has not been replaced.
Bile duct and gallbladder cancers are together called biliary tract cancers. For many years the choices were surgery when possible, then chemotherapy. That is still the base. What is new is that doctors can now read the genes of a tumour and match a medicine to it, and that a second kind of medicine can be added to the usual chemotherapy.
| Change | Who it is for | Where it stands |
|---|---|---|
| Immune medicine added to gemcitabine and cisplatin | Cancer that cannot be removed, or has returned | Now part of usual care |
| Targeted tablets for a gene change such as FGFR2 or IDH1 | Those whose tumour test shows that change, mostly inside the liver | Used after first chemotherapy |
| Medicines for HER2-positive tumours | Mainly gallbladder and bile duct tumours with high HER2 | In use in some countries; access in India varies |
| Chemotherapy before surgery for large gallbladder cancer | Tumours that look hard to remove | Under trial |
| Blood tests for tumour DNA | After surgery, to judge the risk of return | Under study, not for routine use |
Because the result can open a targeted tablet that works better than chemotherapy for that tumour. The test must be asked for early, on the first tissue.
Tumour cells carry changes in their genes. In biliary cancer a few of these changes have a matching medicine. The test is done on the tissue from a biopsy or an operation. The report is read by a cancer doctor along with the scans.
Ask that the tissue block from your biopsy is kept and sent for a full gene panel. If tissue is too little, a blood version can be tried. A result of no change is also useful, as it tells the team that chemotherapy remains the path.
Adding an immune medicine to gemcitabine and cisplatin helps some people live longer than chemotherapy alone, and is now part of usual first treatment.
Immune medicines help the body see the cancer. Trials of two such medicines, given with the usual two-drug chemotherapy, showed a gain in survival over chemotherapy alone. The extra drug is given by drip, usually on the same day.
The gain is real but modest, and side effects need watching. The immune system can inflame the skin, gut, liver or thyroid. Report diarrhoea, rash, new cough or yellowing early, because these are treated well when caught early.
Capecitabine tablets for about six months are still the standard after surgery. Trials are asking whether stronger plans work better, and results are awaited.
After an operation that removes the cancer, capecitabine lowers the chance that it returns. It is taken at home in cycles. Several trials are now testing other plans, such as gemcitabine with cisplatin, or adding an immune medicine or a targeted drug in those with a matching gene change.
Until those results are out, capecitabine remains the advice. If a trial is open near you and you fit its rules, your cancer doctor may suggest joining. Joining is a choice, and you can step out at any time.
For large gallbladder cancers that look hard to remove, chemotherapy first is being tested. It is not yet routine, and the decision is made case by case.
Many gallbladder cancers are found late, after an operation for stones, or when they are already large. Some Indian and Western trials are testing chemotherapy first, so the tumour shrinks and an operation becomes possible. Only those whose cancer responds go on to surgery.
If the cancer is clearly removable now, waiting for chemotherapy first is not advised outside a trial.
Blood tests for tumour DNA and better imaging during surgery are promising, but they are still being studied. They do not yet change standard advice.
A blood test can sometimes find tiny bits of tumour DNA after an operation. Researchers want to learn whether this can show who needs extra treatment. For now it is a research tool, so it should not be used alone to decide on more chemotherapy.
In the operating room, a green dye with a special camera helps show the bile ducts, and 3D models from the scan help plan how much liver to remove. Dr Harsh Shah does these operations by keyhole or open surgery, and does not use a robot.
Ask for a tumour gene test, keep your tissue block, and see a team that offers surgery first when it is possible. Do not chase a new medicine in place of a safe operation.
Yes, in two ways. An immune medicine is now added to the usual chemotherapy, and tumour tests can find a change that a targeted tablet can act on. Surgery stays the main treatment whenever the cancer can be removed.
Ask for a panel that looks at HER2, FGFR2, IDH1, BRAF and MSI status. It is done on the biopsy or operation tissue. A blood version exists for those whose tissue is too little.
No. A medicine cannot take the place of a clean operation when the cancer can be removed. The new medicines help when surgery is not possible, or when the cancer returns.
Capecitabine tablets for about six months remain the standard. Trials are comparing stronger plans, and the results are awaited. Your cancer doctor will tell you if the advice changes.
It is being tested in trials, mainly for large tumours that look hard to remove. It is not yet the routine for everyone. Your surgeon and cancer doctor decide together.
Blood tests that look for tumour DNA are still under study. They are not yet used to decide treatment, so do not pay for one on its own without advice.
Availability and cost vary, and some are given only through trials or access programmes. Ask your cancer doctor which medicine suits your tumour test, and what is available to you.
For the full picture of these cancers and their care, start at the biliary tract cancer treatment page. For the cancer that sits at the liver gate, see perihilar cholangiocarcinoma treatment. For questions before you travel, call +91-63555-64601.
Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601
Read about new medicines for bile duct or gallbladder cancer and wondering what applies to you? Some are proven, some are still being tested, and none suits everyone. Dr Harsh Shah, a liver and gastro surgeon in Ahmedabad, reviews your reports and your tumour tests, and explains in plain words what is worth doing now. Bring every report, scan film and biopsy slide. You can also call us or write on WhatsApp. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.